Azione 4530 HISAMITSU PHARMACEUTICAL CO., INC.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Hisamitsu Pharmaceutical Co., Inc.

Azioni

4530

JP3784600003

Mercato chiuso - Japan Exchange
Altri mercati azionari
 08:00:00 08/07/2024 		Variaz. 5gg Var. 1 gen.
3.728 JPY -0,48% Grafico intraday di Hisamitsu Pharmaceutical Co., Inc. +0,30% -13,52%
23/05 Hisamitsu Pharmaceutical Co., Inc. (TSE:4530) annuncia un programma di riacquisto di azioni per 2.400.000 azioni, pari al 3,17% per 8.901,6 milioni di yen. CI
23/05 Hisamitsu Pharmaceutical Co., Inc. autorizza un piano di riacquisto. CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!
Registrazione 100% gratuita
Hisamitsu Pharmaceutical Co., Inc.(TSE:4530) dropped from S&P Japan Mid Cap 100
Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on May 23, 2024.
Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback announced on May 23, 2024, has closed with 2,400,000 shares, representing 3.17% for ¥8,901.6 million.
Hisamitsu Pharmaceutical Co., Inc. announces an Equity Buyback for 2,400,000 shares, representing 3.17% for ¥8,901.6 million.
Hisamitsu Pharmaceutical Co., Inc. authorizes a Buyback Plan.
Hisamitsu Pharmaceutical : Notice of Convocation of the 122nd Annual General Meeting of Shareholders
Hisamitsu Pharmaceutical Attributable Profit Up 19% in Fiscal 2024
Hisamitsu Pharmaceutical : Earning Document
Hisamitsu Pharmaceutical : Notification of Completion of Construction of the New Research Laboratory “SAGA Global Research Center”
Hisamitsu Pharmaceutical Lifts Fiscal-Year Targets as Nine-Month Profit, Net Sales Rise
Hisamitsu Pharmaceutical Co., Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending February 29, 2024
Hisamitsu Pharmaceutical Co., Inc. Announces Dividend for the Second Quarter and Provides Dividend Guidance for the Full Year Ending February 29, 2024
Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on July 13, 2023.
Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback announced on July 13, 2023, has closed with 2,000,000 shares, representing 2.58% for ¥9,792.58 million.
Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on July 13, 2023.
Hisamitsu Pharmaceutical : Notice Regarding Status of Acquisition of Treasury Shares
Hisamitsu Pharmaceutical : Announcement regarding completion of partial transfer of assets, related to S-Cup and Lacalut from SSP Co., Ltd.
Hisamitsu Pharmaceutical’s Attributable Profit up 29.4% in Fiscal Q2 on Improved Net Sales
Hisamitsu Pharmaceutical : Earning Document
Hisamitsu Pharmaceutical : Earning Document
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione 4530
  4. Notizie Hisamitsu Pharmaceutical Co., Inc.
  5. Altre lingue